Ms Stem Cell Treatment Canada

The most studied type of stem cell therapy for ms is autologous haematopoietic stem cell transplantation often shortened to ahsct asct or hsct.

Ms stem cell treatment canada.

Rush says while there s no cure for ms stem cell transplant is the closest thing and for patients in canada the ottawa hospital is a leader in offering this treatment. The ms society of canada has announced funding for the first clinical trial of its kind in canada studying the ability of mesenchymal stem cells to treat ms. The discovered potential of msc in treating ms has culminated in the launch of mescams mesenchymal stem cell therapy for canadian ms patients a phase ii clinical trial that is funded in part by the ms scientific research foundation research manitoba and a w food services of canada inc. Stem cell therapy is any treatment that uses or targets stem cells which are the types of cells that differentiate into many different specialized cells in our bodies.

That compared with only three of 55 patients given a stem cell transplant. Stem cells are found in both embryos and adults. One trial of 24 people with rrms found that 69 who had stem cell therapy didn t have a relapse in ms symptoms or new brain lesions which are caused by ms 5 years after treatment. Stem cell tourism provides unproven stem cell treatments.

Mesenychmal stem cells are found in many parts of the body including the bone marrow skin and fat. Although stem cell therapy is routinely used for conditions such as cancer of the blood leukaemia it s still largely seen as an experimental treatment for multiple sclerosis ms. They have been shown to suppress inflammation and repair nerve tissue positioning them as promising candidates for the treatment of ms. The program often includes patients and families traveling to countries outside of the united states where the procedure s performed.

Mark freedman ottawa hospital research. The discovered potential of mesenchymal stem cells msc in treating multiple sclerosis ms has culminated in the launch of mescams mesenchymal stem cell therapy for canadian ms patients a phase ii clinical trial that is funded in part by the ms scientific research foundation research manitoba and a w food services of canada inc. Mark freedman ottawa hospital.